Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
200 participants
INTERVENTIONAL
2020-11-05
2021-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractal and Morphometric Analysis of Mandibular Bone in Periodontitis
NCT07209579
Fractalkine-CX3CR1 Axis in Periodontal Therapy
NCT07307144
Evaluation of the Effects of Smoking on Trabecular Bone Microarchitecture Using CBCT in Periodontal Disease
NCT06676358
Changes in Periodontal Pocket Depth After Periodontal Treatment
NCT07327658
Determining the Relationship Between the Atherosclerosis and Periodontopathogenic Microorganisms
NCT02977351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Method: The study included 50 periodontally healthy individuals (control group), 50 individuals with Stage 1 periodontitis (S1-P group), 50 individuals with Stage 2 periodontitis (S2-P), and 50 individuals with Stage 3 periodontitis (S3-P), a total of 200 individuals were included. The fractal dimension (FD) value of the trabecular bone in the interproximal space between mandibular first molar and second premolar tooth roots was evaluated using Image J program. The mean fractal dimension values of the two regions were calculated by box counting method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
periodontally healthy individuals
50 subject without any periodontal disease
fractal analysis
fractal analysis is a method that numerically expresses bone changes.
Stage 1 periodontitis
50 subject diagnosed with stage 1 in the periodontal disease classification
fractal analysis
fractal analysis is a method that numerically expresses bone changes.
Stage 2 periodontitis
50 subject diagnosed with stage 2 in the periodontal disease classification
fractal analysis
fractal analysis is a method that numerically expresses bone changes.
Stage 3 periodontitis
50 subject diagnosed with stage 3 in the periodontal disease classification
fractal analysis
fractal analysis is a method that numerically expresses bone changes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fractal analysis
fractal analysis is a method that numerically expresses bone changes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Getting a diagnosis of stage 1,2 and 3 periodontitis
* Be diagnosed as periodontally healthy
* Have no barriers to obtaining radiographs
* Not having any systemic disease that may affect periodontal status
* Not smoking and alcohol use
* Volunteer to participate in the study
Exclusion Criteria
* Radiographs with poor diagnostic quality
* Root canal treatment or teeth with periapical lesions in the area of interest
* Individuals who have suffered a fracture or trauma that affects the anatomy or integrity
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Necmettin Erbakan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ummuhan Tekin Atay
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necmettin Erbakan University
Konya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ummuhantekinatay
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.